Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Menopause affects hair and skin; more research needed for treatment.

Peppermint oil can effectively promote hair growth without being toxic.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

Minoxidil in HA-PLGA nanoparticles effectively treats alopecia through skin delivery.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Microparticles containing artocarpin extract could effectively treat hair loss and acne with minimal side effects.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Cilostazol helps hair grow by making hair root cells grow faster and changing growth factor levels.

The gel with special fat-loaded particles from rice bran could be an effective skin treatment for hair loss.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

A 10-year-old girl with Fox Fordyce disease improved with treatment, suggesting the disease can occur before puberty and might be underdiagnosed in young girls.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Fox Fordyce disease might be more common in prepubertal girls than thought and can be managed with treatment.

Hair mineral content can help diagnose certain common illnesses.

A new mutation in the ST14 gene causes a rare skin and hair disorder in a specific family.

Human hair varies widely and should be classified by curl type rather than race.

AGA patients have higher heart disease risk.

Patients with both connective tissue disease and acid reflux are more likely to have certain symptoms and physical signs.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.